Roche Extends Tender Offer for Spark Therapeutics
December 09 2019 - 2:16AM
Dow Jones News
By Kim Richters
Roche Holding AG (RO.EB) said Monday that it has extended the
offer period for its planned takeover of biotechnology company
Spark Therapeutics Inc. (ONCE) to Dec. 16.
Swiss pharmaceutical company Roche said the offer was extended
to provide additional time for the U.S. Federal Trade Commission
and the U.K. Competition and Markets Authority to complete their
reviews of the pending acquisition.
The period for Roche's offer of $114.50 per share has been
extended several times and was set to expire on Dec. 10.
As of Dec. 6, around 14.9% of Spark's outstanding shares had
been tendered, according to Roche.
Write to Kim Richters at kim.richters@wsj.com
(END) Dow Jones Newswires
December 09, 2019 02:01 ET (07:01 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
Roche (QX) (USOTC:RHHBY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Roche (QX) (USOTC:RHHBY)
Historical Stock Chart
From Apr 2023 to Apr 2024
